Conference Reports for NATAP
Conference on Retroviruses
and Opportunistic Infections
San Francisco, CA
March 9-12 2025
Back
Tweet
Proof-of-Concept Trial of Oral VH4011499 (VH-499), a New HIV-1 Capsid Inhibitor
CROI 2025 SF March 9-12